Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

151
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
151
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

828
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
828
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

313
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
313
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

975
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
975
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

156
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
156
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

640
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
640

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel maternal prenatal risk index to predict mortality-weighted severe maternal morbidity at hospitalization: a retrospective cohort study.

Lancet regional health. Americas·2026
Same author

Information-Based Composite Likelihood Method for Hybrid Meta-Analysis Integrating Individual Participant Data and Aggregated Data.

Statistics in medicine·2026
Same author

Vaccine efficacy estimands and power considerations.

Statistical methods in medical research·2026
Same author

Canopy2: Tumor Phylogeny Inference by Bulk DNA and Single-Cell RNA Sequencing.

Statistics in biosciences·2026
Same author

Mortality-weighted severe maternal morbidity: a novel approach to assessing maternal health outcomes.

BMC pregnancy and childbirth·2025
Same author

Pair-Feeding Study Designs Can Create Biases and Inflate Type I Error Rates: A Simulation Study.

Obesity (Silver Spring, Md.)·2025
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Oct 27, 2025

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.1K

Bayesian multiregional clinical trials using model averaging.

Nathan W Bean1, Joseph G Ibrahim1, Matthew A Psioda1

  • 1Department of Biostatistics, University of North Carolina, McGavran-Greenberg Hall, CB #7420, Chapel Hill, NC 27599, USA.

Biostatistics (Oxford, England)
|July 23, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a new Bayesian method for analyzing multiregional clinical trials (MRCTs). The approach improves region-specific effect estimation and quantifies treatment effect consistency for drug approval.

Keywords:
Bayesian clinical trialsBayesian model averagingGlobal consistencyGlobal treatment effectLocal consistencyMultiregional clinical trialsRegion-specific treatment effects

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Related Experiment Videos

Last Updated: Oct 27, 2025

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.1K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacometrics

Background:

  • Multiregional clinical trials (MRCTs) accelerate global drug introduction but face challenges with small regional sample sizes impacting effect estimation.
  • Current statistical methods struggle with region-specific inference in MRCTs, despite the International Conference for Harmonisation E17 guideline supporting their use.

Purpose of the Study:

  • To develop a novel Bayesian methodology for estimating region-specific and global treatment effects in MRCTs.
  • To provide a metric for assessing treatment effect consistency across regions, aiding regulatory drug approval.
  • To enhance the quality of inference for region-specific effects in MRCTs.

Main Methods:

  • Bayesian model averaging applied to MRCTs with continuous outcomes and covariates.
  • Incorporation of patient characteristics via covariate inclusion.
  • Development of posterior model probabilities to quantify evidence for treatment effect consistency.

Main Results:

  • The proposed Bayesian model averaging approach yields lower Mean Squared Error (MSE) compared to fixed-effects linear regression.
  • Demonstrated superior control of Type I error rates relative to Bayesian hierarchical models in simulations.
  • Quantified evidence for consistency of treatment effects across regions.

Conclusions:

  • The novel Bayesian methodology offers improved estimation of region-specific and global treatment effects in MRCTs.
  • Posterior model probabilities provide a valuable tool for regulatory assessment of treatment effect consistency.
  • This approach addresses key statistical challenges in MRCTs, supporting more reliable drug development and approval.